KollegeApply logo

KollegeApply

IIM Bodh Gaya Convergence 2.0 on Emerging Technologies in Healthcare

2 minute read

• Updated on 15 Sep, 2025, by Kollegeapply

IIM Bodh Gaya Convergence 2.0 on Emerging Technologies in Healthcare

The Indian Institute of Management, Bodh Gaya, organized Convergence 2.0, a leadership summit themed “Re-imagining Healthcare Ecosystem with Technological Advancements”. Medical experts, industry leaders, clinicians, and innovators shared insights into how technologies are transforming healthcare in India.

 

Key Highlights from Convergence 2.0 at IIM Bodh Gaya

Topic

What Was Discussed

Panel Discussions

Featured senior practitioners and leaders discussing supply-chain resilience, affordable access to innovative therapies, the role of clinical trials, immunotherapy, and vaccines.

Emerging Technologies

AI-driven diagnostics, telemedicine, connected medical devices, data intelligence, personalised medicine.

Industry & Academia Integration

Need for equitable, scalable healthcare; establishing knowledge exchange between industry and academia.

 

Institutional Perspective & Program Initiatives

Vinita S. Sahay, Director of IIM Bodh Gaya, emphasized that an India-specific model for healthcare is needed—one that balances affordability + strength in both body and community. Chairperson of the MBA in Hospital & Healthcare Management Programme, Swapnarag Swain, noted the institute’s commitment to making the programme industry-centric and practice-oriented.

 

Experts & Participants

Some of the prominent attendees included:

  • Ajay Bagga, MD & Country Head, Zimmer Biomet
  • Manish Sardana, MD & GM, South Asia, Vygon
  • Ram Panda, MD, Healthcare & Life Sciences, Alvarez & Marsal
  • Bhupendra Tripathi, Deputy Director, Gates Foundation
  • Pragati Awasthi, Group VP, Romsons Group
  • Lalit Kanodia, VP, Hospitals & Corporate Services, Tata 1mg
  • Anith Sankaran, Head of Supply Chain, Shalby MedTech

 

Actionable Recommendations from the Summit

Some of the suggestions put forth during Convergence 2.0 included:

  • Strengthening interoperability of health data and medical record systems
  • Ensuring affordability and access to new therapies, while maintaining quality and innovation
  • Fostering indigenous manufacturing (Make in India) of medical devices and life sciences equipment
  • Emphasis on regulatory reforms, ethical deployment of AI, and robust clinical trial infrastructure
Students learning mobile

Your opinion matters to us!

Rate your experience using this page so far.